Trials / Completed
CompletedNCT05088174
A Trial of Hetrombopag in Healthy Subjects
A Single-Center, Single-Arm, Open-Label, Self-Controlled, Drug-Drug Interaction Study of Hetrombopag Olamine and Ciclosporin in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-center, single-arm, open-label, self-controlled, phase I clinical study. A total of 26 male or female healthy subjects are intended to be enrolled to evaluate the PK drug-drug interaction between ciclosporin and hetrombopag.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hetrombopag Olamine Tablet；Ciclosporin Soft Capsule | Drug: Hetrombopag Olamine Tablet Ciclosporin Soft Capsule |
Timeline
- Start date
- 2020-09-03
- Primary completion
- 2020-10-22
- Completion
- 2020-10-22
- First posted
- 2021-10-21
- Last updated
- 2021-10-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05088174. Inclusion in this directory is not an endorsement.